What Does the Omicron Variant Mean for Vaccine Stocks?
In case you've been living under a rock, you already know that the recently discovered omicron variant of SARS-CoV-2 is spreading globally, and it could be somewhat resistant to the coronavirus vaccines on the market. That's alarming enough on its own -- and if you're invested in some of the leading vaccine stocks, omicron potentially poses an additional concern.
After all, national healthcare systems won't be clamoring to purchase jabs that are proven to be poorly effective against this new variant. So omicron could change the competitive landscape for coronavirus vaccines just as the delta variant did before it.
Let's analyze what that means for a few of the most important vaccine makers and try to understand how it might impact their share prices.
Source Fool.com
